Investors continue to be optimistic about Medtronic due to strength in its Neurosurgery portfolio. Yet, mounting expenses pose a threat to the company's margins.

The QPAN® Model, or QEEG-Guided Personalised AI-Based Neuromodulation and Rehabilitation, is an innovative therapeutic ...

Analyst reviews BrainsWay's rising share price and recent $20 million private placement, speculating on potential M&A plans ...

Micro-Leads Pioneers Medical Breakthrough in a 20 Participant Human Study with HD64, the World's First Spine-Chip SOMERVILLE, ...

NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq:HSDT) has announced promising preliminary findings from its PoNSTEP study, which evaluates the impact of adherence to the Portable ...

Theranica, a prescribed neuromodulation therapeutics company, today announced Medicaid coverage for the Nerivio® REN wearable in four more states: Arizona, New Jersey, Ohio, and Virginia, extending ...

Hamad Medical Corporation (HMC) announcedthe launch of two innovative treatment options for patients with treatment resistant ...

Approximately 10% to 20% of total knee arthroplasty (TKA) patients have persistent postoperative pain. Data from a new ...

California Governor Gavin Newsome signed a new law over the weekend that protects brain data from being misused by ...

T. Rowe Price, a global investment management firm and leader in retirement, announced it is forming the T. Rowe Price ...

Hamad Medical Corporation (HMC) has launched two innovative options – Esketamine and Transcranial Magnetic Stimulation (TMS) ...

Achieves primary endpoint showing a linear relationship between adherence to PoNS Therapy® in Phase 2 and improvement in DGI scores from Phase ...